Loading...
Market
Which major pharmaceutical company will license the 'Supermodel granny' drug by the end of 2024?
2
Resolution / Starting Odds
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
Public announcements from pharmaceutical companies
Story
'Supermodel Granny' Drug Extends Animal Lifespan by Blocking Interleukin-11, Nature Study Finds
Jul 17, 2024, 04:51 PM
A new drug, referred to as the 'Supermodel granny' drug, has shown promising results in extending the lifespan of animals. The drug works by blocking inflammation, specifically targeting interleukin-11, according to recent research published in Nature. This discovery, which involves interleukin-11 knockout or inhibition, could pave the way for the development of anti-aging drugs, offering a potential breakthrough in lifespan and healthspan expansion. However, questions remain about the short lifespan of control mice used in the study.
View original story
Similar markets
Pfizer • 25%
Johnson & Johnson • 25%
Roche • 25%
Other • 25%
Pfizer • 25%
AstraZeneca • 25%
GlaxoSmithKline • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Pfizer • 25%
Roche • 25%
GlaxoSmithKline • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Roche • 25%
Other • 25%
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Eli Lilly • 25%
Viking Therapeutics • 25%
Pfizer • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%